Filing Details
- Accession Number:
- 0000315066-22-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-28 17:04:12
- Reporting Period:
- 2022-01-26
- Accepted Time:
- 2022-01-28 17:04:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840574 | Verve Therapeutics Inc. | VERV | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-26 | 14,918 | $29.67 | 1,022,376 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Common Stock | Disposition | 2022-01-26 | 88,989 | $31.12 | 933,387 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Common Stock | Disposition | 2022-01-26 | 45,946 | $31.96 | 887,441 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Common Stock | Disposition | 2022-01-27 | 8,736 | $29.26 | 878,705 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Common Stock | Disposition | 2022-01-27 | 247 | $30.02 | 878,458 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
Footnotes
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $29.50 to $30.50. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $30.60 to $31.60. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $31.60 to $32.36. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $29.00 to $30.00. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $30.01 to $30.04. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
